BOSTON, June 28, 2016 /PRNewswire/ -- ORIG3N, Inc., pioneering the future of medicine through genetics and regenerative medicine research and the San Francisco 49ers, today announced a unique partnership that will reward fans for contributing to the future of human genome analysis. As part of the multi-year agreement, ORIG3N will play a featured role in enhancing the fan experience outside Levi's® Stadium with a location where fans can purchase LifeProfile genetic assessments and donate a sample of blood to LifeCapsule, the world's largest crowdsourced cell repository that is used to advance future medical and human genome research.
Each fan who participates in the ORIG3N experience will become part of the Faithful DNA program which rewards and recognizes individuals who donate a blood sample to LifeCapsule or sign up for a LifeProfile. The Faithful DNA program will provide patrons who donate their DNA to human genome research with the opportunity to win exclusive 49ers experiences and prizes.
"This is the first agreement of its kind and we're excited to provide our fans with a unique opportunity to form personal connections with the 49ers in a way that contributes to human genome research," said 49ers COO Ethan Casson. "We are always looking for ways to enhance our fan experience and we believe we've done that in a ground-breaking way by partnering with a pioneering company like ORIG3N to give our fans the chance to compare their genetic makeup to that of professional football players."
"We're appreciative of the support the 49ers organization is putting behind our mission of crowdsourcing samples to advance human genome research and the future of medicine," said Robin Y. Smith, CEO of ORIG3N. "This agreement is a major milestone in our company evolution and is a testament to how much our mission resonates with so many. A big thank you to the 49ers fan community—we're very excited to be part of the Faithful DNA!"
LifeCapsule is a crowdsourced cell repository of blood samples collected from locations throughout the world and is used to better understand the causes and treatments of rare genetically inherited diseases. Each sample is used to generate induced pluripotent stem cells (iPSCs) that are then used to grow different cell types, including neurons, heart and liver cells.
LifeProfiles are genetic tests that provide information about a person's genetic tendencies related to fitness, endurance, strength and metabolism.
In addition to the Faithful DNA program, ORIG3N will be receiving advertising rights within Levi's® Stadium.
About ORIG3N, Inc.
ORIG3N is advancing the future of medicine through genetics and regenerative medicine research. The company is doing so by engaging directly with consumers and giving consumers the opportunity to understand their genetic makeup while building the world's largest crowdsourced library of blood samples to support induced pluripotent stem cell research. The cell repository, called LifeCapsule, is used to better understand the cellular and molecular foundations of genetically inherited disease. Thousands of people have already contributed to advancing the future of medicine and human genome research. The founders are serial entrepreneurs whose previous venture, ArtusLabs, was acquired by PerkinElmer in 2011.
For more information, visit www.orig3n.com.
About the San Francisco 49ers
The San Francisco 49ers, owned by Denise and John York, currently play in the NFC West division and have won five Super Bowl trophies including Super Bowl XVI, XIX, XXIII, XXIV and XXIX. The franchise also has six conference championships and 19 divisional championships and was the first major league professional sports team to be based in San Francisco over 60 years ago. Please visit www.49ers.com and follow the 49ers on Facebook and Twitter @49ers.
-- 49ers.com --
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orig3n-partners-with-san-francisco-49ers-to-reward-fans-for-contributions-to-advancing-the-future-of-medicine-through-genetics-and-regenerative-medicine-research-300291198.html
SOURCE ORIG3N, Inc.